Update on non-muscle invasive bladder cancerCytoreductive nephrectomy in the era of targeted molecular agents: is it time toconsider pre-surgical therapy?• Invited Lecturer, Innovations in Urology First Annual Meeting, Milan, Italy 9/18/2010Pelvic Lymph Node Dissection for Prostate Cancer: extended, limited, or not at all?• Invited Lecturer, Seventh Annual Current Trends in Genitourinary Maligancies, 10/16/2010New York, NY.Surgery for early-stage bladder cancer. Debate: radiation therapy is suboptimal for bladdercancer.• Invited Lecturer at the session Prostate Cancer II of the 7th Men’s Health World 10/29/2010Congress and 3rd European Men’s Health Conference. 28-30 October 2010, Nice, France.Prostate cancer overview and recent advances - how can a common disease be so controversial• Invited Lecturer at the 7th Men’s Health World Congress and 3rd European Men’s 10/29/2010Health Conference. Update on the management of bladder cancer in 2010• Invited Lecturer, 4 th Journee d’ onco-urologie of the Association Marocaine 12/18/2010d’Urologie, Fes, Morocco.Recent advances in prostate cancer –a controversial common diseaseManagement of non-invasive bladder cancer• Lecturer, ICUD-EAU International Consultation on Bladder cancer 2011 3/18/2011Chapter 3: Markers• Lecturer, European Society of Residents in Urology and Young Urologists Office 3/19/2011<strong>Vienna</strong>, AustriaHow to make it in UrologyPanel discussion on career challenges in 2011• Lecturer, ESU Course 20 How to write a manuscript and get it published in 3/21/2011European Urology, <strong>Vienna</strong>, AustriaClinical research original article: how to write the best introduction sectionClinical research original article: how to write the results and discussion sectionsReview article: the critical interpretation of the summarized evidence: why is the author’s touch ofclass essential to write the perfect manuscript?• Lecturer, Sub-plenary session 8: ICUD-EAU International Consultation on Bladder cancer 3/21/2011<strong>Vienna</strong>, AustriaMarkers of early detection in bladder cancerPrognostic/predictive markers in bladder cancer• Invited Lecturer, 44. Alpenländische Urologensymposium, Wolkenstein, Bozen, IT 4/1/2011Integration neuer Biomarker in der Diagnostik und Therapie von BlasenkarzinomOptimales Management des invasiven Blasenkarzinoms- Wertigkeit der Chirurgie unterIntegration der Chemotherapie• Panel – Management of the small renal mass. EAU 4 th leading light meeting.4/9/20117-9 April 2011, Lago Maggiore, Italy (4/9/11)• Invited Lecturer, Tumor board at Columbia University College of Physicians 4/19/2011and SurgeonsUpper tract urothelial carcinoma: new data and old news• Invited Lecturer, Association Marocaine d’Urologie Annual Meeting 2011 4/28-29/2011Skhirat, Morocco.Biomarkers for early detectionManagement of T1 high grade urothelial carcinoma of the bladderPanel discussion on bladder cancerwww.vienna-omi.at 28.08.2013
Ablative therapy for small renal cortical tumors• Invited Lecturer, Interactive Genitourinary Cancer Conference (IGUCC)4/30/2011Budapest, Hungary.Interpreting trends in prostate cancerPanel discussion on prostate cancer biomarkers• Course lecturer, American Urological Association Annual Meeting, Washington, DC 5/17/2011Multidisciplinary management of urothelial carcinoma: stage- and site-specific discussionsupper tract urothelial carcinoma• Invited Lecturer, Societa Italiana di Urologia Oncologica (SIUrO), Naples, Italy 6/23-24/11Clinical utility of nuclear matrix protein 22 for the management of bladder cancerLymphadenectomy for prostate cancer: extended, standard, limited or not at all?• Course lecturer, ESU-Weill Cornell Masterclass in General urology, Salzburg, AUT 7/11-15/2011Management of localized prostate cancerManagement of metastatic prostate cancerManagement of penile cancerManagement of upper tract urothelial carcinoma• Invited lecturer, AUA Foundation/Society of Basic Urologic Research Conference 7/16-17/2011AUA Headquarters, Linthicum, MD, USAAging and urothelial carcinoma:an oncogeriatric matter• Invited lecturer, New York Section of the American Urological Association9/11/2011109 th Annual Meeting, Paris, FranceBladder-sparing approaches to invasive bladder cancerThe role of early cystectomy in muscle invasive bladder cancer• Invited lecturer, 8 th Men’s health world congress a n d 4 th European men’s 10/3-4/2011health conference, <strong>Vienna</strong>, AUTEarly androgen deprivation- what is the evidence?Integration of multidisciplinary care in the management of high-risk prostate cancer• Invited lecturer, Andrologisch-Onkologisches Herbstseminar10/8/2011Arbeitskreise für Andrologie und Onkologie, Berufsverband der Österreichischen UrologenDas Prostatakarzinom: warum bestehen bei einer so häufigen Erkrankung so viele Kontroversen?• Invited lecturer, 5 th Global Uro-Oncology Meeting under the auspices of the 10/15-16/2011World Urological Oncology Federation, Berlin, GermanyManagement of invasive bladder cancer in the elderly• Course lecturer, 31 st Congress of the Societe International d’Urologie, Berlin , DE 10/19/2011Updates on upper tract urothelial carcinoma: diagnosis, staging, and management• Invited lecturer, Menopause, Andropause, Anti-aging. 8-10 December, <strong>Vienna</strong>, AUT 12/2011Das Prostatkarzinom: eine paradoxe Krankheit• Invited lecturer, 5 th EAU Leading Lights in Urology Meeting. March 29-30, Madrid, SPA3/2012The risks of 5α-reductase inhibitors for prostate cancer preventionThe role of neoadjuvant and adjuvant treatment in advanced bladder cancerThe future of urologic oncology researchwww.vienna-omi.at 28.08.2013
- Page 1 and 2: SHAHROKH F. SHARIAT, MDProfessor an
- Page 3 and 4: E D U C A T I O N & M E D I C A L T
- Page 5 and 6: • Glaxo SmithKline Scholar Award,
- Page 7 and 8: May 29-June 3, 2010. J.Urol 183(4):
- Page 9 and 10: • Leading Physician of the World
- Page 11 and 12: Weill Cornell Medical Center, Princ
- Page 13 and 14: Inventor: Shahrokh ShariatThe prese
- Page 15 and 16: • Chair of Sessions - The Inaugur
- Page 17 and 18: • Guest Editor of special issue o
- Page 19: • Visiting Professor, Division of
- Page 23 and 24: Bladder cancer: opportunities for i
- Page 25 and 26: 7. Merseburger AS, Herrmann TR, Sha
- Page 27 and 28: 36. May M, Ficarra V, Shariat SF, Z
- Page 29 and 30: Results from of a Large Multicenter
- Page 31 and 32: trends and disparities in the use o
- Page 33 and 34: 112. Abdollah F, Sun M, Thuret R, J
- Page 35 and 36: 139. Fajkovic H, Cha EK, Jeldres C,
- Page 37 and 38: RK, Margulis V, Shariat SF: Tissue-
- Page 39 and 40: 21869907190. Abdollah F, Sun M, Jel
- Page 41 and 42: Montorsi F, Karakiewicz PI: The imp
- Page 43 and 44: Fradet Y, Shariat SF. Prognostic ri
- Page 45 and 46: 271. Shariat SF, Lotan Y, Vickers A
- Page 47 and 48: 298. Shariat SF, Kattan MW, Vickers
- Page 49 and 50: 324. Capitanio U, Isbarn H, Shariat
- Page 51 and 52: 349. Margulis V, Shariat SF, Matin
- Page 53 and 54: 378. Karakiewicz PI, Bhojani N, Cap
- Page 55 and 56: 410. Shariat SF, Lamb DJ, Iyengar R
- Page 57 and 58: 442. Chun FK, Briganti A, Gallina A
- Page 59 and 60: cystectomy for primary nontransitio
- Page 61 and 62: Slawin KM. Salvage radiotherapy for
- Page 63 and 64: 535. Shariat SF, Desai S, Song W, K
- Page 65 and 66: 21. SunM., Abdollah F., Schmitges J
- Page 67 and 68: progression after radical prostatec
- Page 69 and 70: Y., Karakiewicz P.: Assessement of
- Page 71 and 72:
50. Shariat S., Karakiewicz P., Fra
- Page 73 and 74:
predictions in patients with adreno
- Page 75 and 76:
Schoenberg, G. E. Amiel, S. P. Lern
- Page 77 and 78:
113. Claudio Jeldres, Maxime Crepel
- Page 79 and 80:
(volume 183 issue 4 Page e227)134.
- Page 81 and 82:
156. Ramy Youssef, Shahrokh Shariat
- Page 83 and 84:
Localized .Sunday, May 15, 2011 Ame
- Page 85 and 86:
Health Conference. 2-5 October 2011
- Page 87 and 88:
urothelial carcinoma. Poster #155.
- Page 89 and 90:
supplementation on the prevention o
- Page 91 and 92:
for metastatic renal cell carcinoma
- Page 93 and 94:
muscle-invasive urothelial carcinom
- Page 95 and 96:
Shahrokh Shariat Prediction of intr
- Page 97 and 98:
Terrone; Derya Tilki; Daniel Vergho
- Page 99 and 100:
P.I.: Drs. Shahrokh Shariat and Dou